BackPanbela Therapeutics Overview

Panbela Therapeutics Research & Development

Research & Development expenses for PBLA.

Quarterly R&D Expenses

$6.05M
↓ 10.19% YoY

As of Sep 30, 2024

Annual R&D Expenses (TTM)

$24.68M
↑ 37.56% YoY

Trailing 12 months ending Sep 30, 2024

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin